ZURA Zura Bio Ltd: Forvard narx/daromad multiplikatori
Zura Bio Limited (ZURA) molekulalarni sinovdan o'tkazishda tashqi laboratoriyalarga tayanadi, bu esa ishlanmalarning moslashuvchanligini ta'minlaydi. Kutilayotgan sotuvlarga nisbatan narx koeffitsiyenti biznesning fundamental kuchini ko'rsatadi, bunda ushbu parametr darajasini belgilaydi. Aksiyalar narxining dinamikasi iqtisodiy sikllardan ko'ra ko'proq klinik sinovlar natijalariga bog'liq. Qarzsiz holat va balans varag'ining likvidligi kelgusidagi ijobiy pul oqimi uchun asos yaratadi.
zurabio.com (ZURA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Zura Bio Limited|ZURA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Zura Bio|ZURA - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Zura Bio|ZURA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Zura Bio|Tezkor likvidlik zurabio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ZURA - Kompaniyaning sof daromadi|Kelajakdagi foyda Zura Bio Limited|ZURA - Kompaniya qiymatining sof foydaga nisbati|Kelajakdagi narxning foydaga nisbati Zura Bio Limited|ZURA - Narxning foydaga va o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Zura Bio|ZURA - Amortizatsiya chegirilmasdan oldingi operatsion daromad|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Zura Bio|ZURA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi zurabio.com|ZURA - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Zura Bio Limited
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahlili:Zura Bio Limited ZURA
Zura Bio Limited (ZURA) tomonidan tizimli yallig'lanishni davolash uchun noyob sitokin inhibitorlarini ishlab chiqilishi kompaniyani kelajakdagi tijorat muvaffaqiyatiga bog'liq qiladi. Forward P/S koeffitsiyentini tahlil qilish orqali investor kutilayotgan tushumning bir dollari bozor qiymatini aniqlaydi, bu esa yangi terapiyalarning samaradorligi bo'yicha kapitalizatsiyaga kiritilgan optimizm darajasini va biznes o'sish sur'atlari sekinlashgan taqdirda haddan tashqari ko'p to'lov qilish xavfini baholash imkonini beradi.
Zura Bio Limited kimlar bilan raqobatlashadi
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABVX: Forvard narx/daromad multiplikatori|Kelajakdagi narxning daromadga nisbati ADMA|PTGX (Protagonist Therapeutics) - Forvard narx/daromad multiplikatori|immunovant.com (IMVT) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Kiniksa|GRFS: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ADPT|Forvard P/S multiplikatori Celldex Corp (CLDX)|Aurinia Pharmaceuticals - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx BCRX|Vera Therapeutics - Forvard P/S multiplikatori|DNTH: Narxning prognoz qilingan daromadga nisbati|PHVS: Forvard P/S multiplikatori|ABCL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Tourmaline Bio, Inc.|Bozor kapitallashuvining kelajakdagi daromadga nisbati precigen.com PGEN|Forvard narx/daromad multiplikatori PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|Zenas Corp - Narxning prognoz qilingan daromadga nisbati|Immunome, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati gossamerbio.com GOSS|KalVista Pharmaceuticals, Inc. (KALV) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Savara Pharma (SVRA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori RIGL (Rigel Pharmaceuticals)|Narxning kutilayotgan daromadga nisbati ANAB|Forvard P/S multiplikatori ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|JBIO (Aerovate Therapeutics Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|Kelajakdagi narxning daromadga nisbati KYTX (kyvernatx.com)|Forvard narx/daromad multiplikatori TLSA|Forvard P/S multiplikatori Cabaletta Bio Inc.|Narxning prognoz qilingan daromadga nisbati Ventyx Bio (VTYX)|THTX (Theratechnologies, Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|Forvard P/S multiplikatori eledon.com ELDN|AGEN - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati CLYM|ATYR: Forvard P/S multiplikatori|Adagene Inc. - Sotuvga nisbatan forvard narx|IMA (ImageneBio) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Shattuck Therapeutics|Narxning prognoz qilingan daromadga nisbati Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Immunic IMUX|ATRA - Forvard narx/daromad multiplikatori|InflaRx GmbH - Forvard P/S multiplikatori|XFOR - Forvard P/S multiplikatori|ACET (adicetbio.com) - Forvard narx/daromad multiplikatori|Celularity - Sotuvga nisbatan forvard narx|INMB (INmune Bio Corp) - Forvard P/S multiplikatori|Barinthus Biotherapeutics Corp (BRNS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|Forvard narx/daromad multiplikatori sabbiotherapeutics.com SABS|Narxning prognoz qilingan daromadga nisbati Akari Therapeutics Plc AKTX|ENLV - Forvard narx/daromad multiplikatori|QTTB: Forvard narx/daromad multiplikatori|GOVX - Forvard P/S multiplikatori|Edesa Biotech, Inc. (EDSA) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IBIO|CARM (Carisma Therapeutics Inc) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati XTL Biopharmaceuticals Ltd XTLB|Forvard narx/daromad multiplikatori BOLT (Bolt Biotherapeutics)|HCWB: Kelajakdagi narxning daromadga nisbati|Aptevo Therapeutics Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori AIM ImmunoTech, Inc. AIM|ADTX - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx GRI (GRI Bio Inc)|XRTX: Forvard P/S multiplikatori|Vyome Therapeutics (HIND) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori REVB|INDP: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SCNI|Narxning prognoz qilingan daromadga nisbati CALI (calcimedica.com)|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Allakos Inc (ALLK)|HOOK - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati IGM Biosciences, Inc.|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Inc - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Narxning prognoz qilingan daromadga nisbati THRD
